News & Analysis as of

Investors Research and Development

McDermott Will & Emery

Key Takeaways | Pharma and MedTech Services Market Overview With McKinsey & Company

McDermott Will & Emery on

During this session, McDermott Partner Kristian Werling and Jeff Smith, a senior partner at McKinsey & Company, shared insights across the pharma and MedTech services industries, including key trends and opportunities shaping...more

McDermott Will & Emery

Pharma and MedTech Services Investment Summit 2024

McDermott Will & Emery on

The inaugural Pharma and MedTech Services Investment Summit brought together C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

McDermott Will & Emery

[Event] Pharma and MedTech Services Investment Summit 2024 - May 2nd, San Francisco, CA

McDermott Will & Emery on

YOUR SOURCE FOR SUCCESS IN PHARMA AND DEVICE SERVICES INVESTING - Join C-suite executives, senior private equity professionals, investment bankers and other industry leaders for a deep dive into the investment...more

Maynard Nexsen

Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 181: South Carolina’s Life Sciences Economy with Ashely...

Maynard Nexsen on

Recorded at SCbio’s 2024 annual conference, hosts Heather and Matthew welcome Ashely Teasdel, Deputy Secretary for the South Carolina Department of Commerce. Ashely is a key player in South Carolina’s economic development and...more

A&O Shearman

Draft EU Foreign Investment Screening Regulation sets out more comprehensive screening regime

A&O Shearman on

On 24 January 2024, the European Commission (EC) published its proposed reform of foreign investment screening in the EU. The proposal introduces more comprehensive rules for the review of foreign investments and strengthens...more

McDermott Will & Emery

Transaction Trends in Life Sciences

In November, we were delighted to once again host our annual European Health & Life Sciences Symposium in Paris. The event attracted a large number of healthcare professionals, investors and dealmakers to the Shangri-La Hotel...more

Morgan Lewis - Health Law Scan

Get Ready, Set, and Go to the JPM Healthcare Conference

As Prescribed and Health Law Scan subscribers know that the end of the holidays means the annual J.P. Morgan (JPM) Healthcare Conference is only days away. To make the most of the 2024 conference and conference-adjacent...more

Latham & Watkins LLP

Life Sciences Product Development Needs More Creative Fundraising

Latham & Watkins LLP on

The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more

Davis Wright Tremaine LLP

Project W: Uncovering a Promising Sector in Climate Tech

The food and ag sectors are tied to nearly a quarter of all global greenhouse gas emissions. However, those sectors receive disproportionately less climate tech venture funding. Beatriz Franco and Maya Benami of Vita Vera...more

Pillsbury Winthrop Shaw Pittman LLP

Exploring R&D Opportunities under the CHIPS Act

The CHIPS R&D Office is advancing innovation and creating opportunities across industry. $11 billion has been appropriated to the CHIPS Research and Development Office to advance research and development of semiconductor...more

DarrowEverett LLP

Florida Business Climate Great for Pickleball, But Risks Are in Play

DarrowEverett LLP on

When discussing the ever-evolving landscape of Florida’s commercial real estate (CRE) market, one trend has begun to stand out — the rise of pickleball. This sport, once a leisurely pastime, has turned into a compelling...more

Maynard Nexsen

Approaching Deadline for the 2022 Benchmark Survey of Foreign Direct Investment in the US: What You Need to Know

Maynard Nexsen on

Foreign direct investment (FDI) plays a crucial role in the global economy, and the United States has long been an attractive destination for international investors. To accurately gauge the impact and trends of FDI, the US...more

Goodwin

Current Issues for Qualified Small Business Stock - How New R&E Expensing Rules Could Hurt Your QSBS Status, and Why Cash...

Goodwin on

An early-stage company can offer prospective investors an attractive investment opportunity, particularly if the company’s stock will qualify as “qualified small business stock” (QSBS) for US federal income tax purposes. This...more

Morrison & Foerster LLP

A New Listing Regime for Specialist Technology Companies Has Arrived

On March 24, 2023, the Stock Exchange of Hong Kong Limited (the “Exchange”) issued the long-awaited consultation conclusions (the “Consultation Conclusions”) on the listing regime for Specialist Technology Companies on the...more

Ballard Spahr LLP

Key Takeaways From the 2023 JP Morgan Healthcare Conference: A Buyers’ M&A Market and More

Ballard Spahr LLP on

Summary - The 41st Annual JP Morgan Healthcare Conference in rainy San Francisco earlier this month was relatively low-key compared to pre-pandemic versions of the health care investment symposium, which returned this year...more

Perkins Coie

Sweeping Appropriations Act of 2023 Makes Unprecedented Investments in AI

Perkins Coie on

Perhaps missed over the holidays, the mammoth $1.7 trillion Consolidated Appropriations Act of 2023 (the Act) was signed into law by President Biden on December 29, 2022. It includes record levels of funding for a wide range...more

Allen Matkins

Life Sciences Real Estate Update -1.06.23 #1

Allen Matkins on

California’s lab and biotech industries provide 435,693 jobs that generate $376 billion in total economic output, according to a new report from Biocom California, an association representing life sciences companies and...more

International Lawyers Network

It`s Not Only Patents: Planning and Implementing to Protect Innovation

For investors in innovation, it is a priority to count on legal mechanisms to secure some level of exclusivity in the exploitation of their innovations, to seek a return on their investment. The first legal alternative...more

Allen Matkins

Life Sciences Real Estate Update - October 2022

Allen Matkins on

Newmark: U.S. life sciences investment dips but main hubs dodge headwinds - Commercial Observer – September 29 - Overall investment in the national life sciences market is shrinking, but the drop in venture capital funding...more

Allen Matkins

Life Sciences Real Estate Update - May 2022

Allen Matkins on

Developers look to office-to-lab conversions to meet life sciences demand Bullet GlobeSt.com – April 29 As demand for lab space among life sciences companies continues to skyrocket, developers are increasingly looking to a...more

Cozen O'Connor

Ceres Guidance for Engaging on Climate Risk Governance and Voting on Directors

Cozen O'Connor on

Ceres, a nonprofit organization focused on solving climate and sustainability challenges through coordinated action by capital market leaders, recently issued its 2022 Guidance for Engaging on Climate Risk Governance and...more

Allen Matkins

Boston Biotech: The Race for New Facilities

Allen Matkins on

Boston has been the undisputed center of the biotech industry for years, and the growth doesn’t appear to be slowing. Allen Matkins partner Martin Togni recently moderated a panel event in Boston to discuss the race for new...more

Allen Matkins

Adaptive Reuse v. New Construction in the Life Sciences Sector

Allen Matkins on

Allen Matkins partner Martin Togni recently moderated a discussion on adaptive reuse and strategic design for converting assets into life sciences lab space hosted by Bisnow. Panelists Susie Harborth, Executive Vice President...more

Goodwin

Client Conversation: Square Mile Capital

Goodwin on

As investors’ demand for life sciences real estate grows at a rapid pace, lenders are actively seeking to lend in this space. Goodwin partner Jarrid King spoke with Eric Juster, Vice President, Investments at Square Mile...more

Dechert LLP

Life Sciences Sector Vision

Dechert LLP on

On 7 July 2021, the UK government (the “Government”) published the UK Life Sciences Vision (the “Vision”) setting out a 10-year strategy for the UK life sciences sector “to solve some of the biggest healthcare problems of our...more

35 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide